Your browser doesn't support javascript.
loading
Prolotherapy agent P2G is associated with upregulation of fibroblast growth factor-2 genetic expression in vitro.
Johnston, Elisha; Emani, Chandrakanth; Kochan, Andrew; Ghebrehawariat, Kidane; Tyburski, John; Johnston, Michael; Rabago, David.
Affiliation
  • Johnston E; Palos Verdes Peninsula High School, 27118 Silver Spur Rd, Rolling Hills Estates, CA, 90274, USA.
  • Emani C; Department of Biology, Western Kentucky University, 1906 College Heights Blvd, Bowling Green, KY, 42101-1080, USA.
  • Kochan A; Healing Arts Research, 4835 Van Nuys Blvd # 100, Sherman Oaks, CA, 91403, USA.
  • Ghebrehawariat K; Independent Researcher, Pittsburgh, PA, 15208, USA.
  • Tyburski J; Nelson Scientific Labs LLC, 44790 Maynard SQ, Ashburn, VA, 20147, USA.
  • Johnston M; Independent Researcher, 5727 Ravenspur Dr. #309, Rancho Palos Verdes, CA, 90275, USA.
  • Rabago D; Department of Family and Community Medicine, Penn State College of Medicine, Hershey, PA, 17033, USA. drabago@pennstatehealth.psu.edu.
J Exp Orthop ; 7(1): 97, 2020 Dec 06.
Article in En | MEDLINE | ID: mdl-33280075
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Type of study: Risk_factors_studies Language: En Journal: J Exp Orthop Year: 2020 Type: Article Affiliation country: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Type of study: Risk_factors_studies Language: En Journal: J Exp Orthop Year: 2020 Type: Article Affiliation country: United States